{"meshTagsMajor":["Mutation"],"meshTags":["Prognosis","Clinical Trials as Topic","Mutation","Humans","Genetic Testing","Survival Analysis","Isocitrate Dehydrogenase","Cytogenetic Analysis","Treatment Outcome","Leukemia, Myeloid, Acute","Diagnosis, Differential"],"meshMinor":["Prognosis","Clinical Trials as Topic","Humans","Genetic Testing","Survival Analysis","Isocitrate Dehydrogenase","Cytogenetic Analysis","Treatment Outcome","Leukemia, Myeloid, Acute","Diagnosis, Differential"],"genes":["IDH2 mutations"],"publicationTypes":["Letter","Research Support, Non-U.S. Gov\u0027t"],"title":"Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia.","pubmedId":"21454467"}